Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal 
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit 
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue 
Nvidia and Groq Strike Strategic AI Inference Licensing Deal 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
LAKE FOREST, Ill., Feb. 15, 2017 -- Stericycle, Inc. (NASDAQ:SRCL) will give a presentation on Monday, March 6th by Charlie Alutto, President and CEO and Dan Ginnetti, CFO, at 9:15 AM Eastern time at the Raymond James 38th Annual Institutional Investors Conference at the JW Marriott Grande Lakes in Orlando, Florida.
On Thursday, March 9th, Stericycle will host one-on-one and group meetings by Dan Ginnetti at the Stifel Executive Summit in Streamsong, Florida.
Stericycle’s press releases and other information are available on the Company’s website at www.stericycle.com.
FOR FURTHER INFORMATION CONTACT: Investor Relations 1-847-607-2012
